Pegasta (pfs) Pegylated r-Human Granulocyte Colony Stimulating Factor 6mg Injection

Name: Pegasta (pfs) Pegylated r-Human Granulocyte Colony Stimulating Factor 6mg Injection
Brand: K T Agencies
Price: 3905.0 INR
Availability: InStock

Price 3905.0 INR/ Box

Get a Price/Quote

MOQ : 100 Packs

Pegasta (pfs) Pegylated r-Human Granulocyte Colony Stimulating Factor 6mg Injection Specification

Origin
India

Indication
Cancer treatment

Dosage Form
Injection

Storage Instructions
Cool and dry place

Shelf Life
12 Months

Pegasta (pfs) Pegylated r-Human Granulocyte Colony Stimulating Factor 6mg Injection Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
7-10 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

Pegasta (pfs) Pegylated r-Human Granulocyte Colony Stimulating Factor 6mg Injection About

Pegasta (pfs) Pegylated r-Human Granulocyte Colony Stimulating Factor 6mg Injection stands as a top-rated option designed for those seeking astoundingly effective support during cancer treatment. Proudly originating from India, this bargain product is well-recognized among healthcare professionals for its polished formulation and premium quality. Ideal for exporters and suppliers, Pegasta offers a hot deal with a 12-month shelf life. For optimal efficacy, store in a cool and dry place. Experience grand results in patient recovery with this trusted injectable therapy.

Astounding Advantages & Practical Usage

Pegasta (pfs) Injection is renowned for its capacity to stimulate white blood cell production, aiding greatly during chemotherapy sessions. Its polished, ready-to-use formulation ensures precise dosing and minimal wastage, positioning it as a reliable choice for clinical and hospital settings. Designed for subcutaneous or intravenous administration, Pegasta is suitable for consistent treatment regimens, making it a grand advancement in supportive cancer care for healthcare providers and patients alike.

Efficient Delivery & Market Reach

Pegasta (pfs) Injection efficiently covers a broad domestic market, reaching numerous cancer care centers throughout India. Our streamlined goods transport system ensures prompt handover and reliable drop-off, minimizing delays. We extend our export network to several main markets across the globe, maintaining uncompromised quality even during international shipping. Customers can trust our robust distribution process for safe and timely delivery of every batch of this essential medication.

FAQ's of Pegasta (pfs) Pegylated r-Human Granulocyte Colony Stimulating Factor 6mg Injection:

Q: How should Pegasta (pfs) Pegylated r-Human Granulocyte Colony Stimulating Factor 6mg Injection be stored for best results?

A: This top-rated injection should be stored in a cool and dry place to maintain its astoundingly effective properties throughout its 12-month shelf life.

Q: What is the main benefit of using Pegasta (pfs) during cancer treatment?

A: Pegasta (pfs) offers grand support by stimulating white blood cell production, reducing infection risk, and helping patients recover faster during chemotherapy.

Q: When is Pegasta (pfs) typically administered?

A: Pegasta (pfs) is usually administered during chemotherapy cycles, as directed by healthcare professionals, to bolster the immune system at the right stage of treatment.

Q: Where does Pegasta (pfs) originate from and who can supply it?

A: This polished injectable medicine is manufactured in India and is available for purchase through reputable exporters and suppliers across different regions.

Q: What is the process for goods transport and delivery of Pegasta (pfs)?

A: Pegasta (pfs) benefits from an efficient goods transport system, ensuring secure handover and prompt drop-off for both domestic and international deliveries.

Q: How is the dosage of Pegasta (pfs) determined and administered?

A: The dosage for Pegasta (pfs) is determined by a healthcare professional based on individual patient needs, and is given as an injection either subcutaneously or intravenously.

Tell us about your requirement